Obesity or a high-fat diet represses the endoribonuclease activity of inositol-requiring enzyme 1 (IRE1), a transducer of the unfolded protein response (UPR) in cells under endoplasmic reticulum (ER) stress. An impaired UPR is associated with hepatic steatosis and nonalcoholic fatty liver disease (NAFLD), which is caused by lipid accumulation in the liver. We found that IRE1 was critical to maintaining lipid homeostasis in the liver by repressing the biogenesis of microRNAs (miRNAs) that regulate lipid mobilization. In mice fed normal chow, the endoribonuclease function of IRE1 processed a subset of precursor miRNAs in the liver, including those of the miR-200 and miR-34 families, such that IRE1 promoted their degradation through the process of regulated IRE1-dependent decay (RIDD). A high-fat diet in mice or hepatic steatosis in patients was associated with the S-nitrosylation of IRE1 and inactivation of its endoribonuclease activity. This resulted in an increased abundance of these miRNA families in the liver and, consequently, a decreased abundance of their targets, which included peroxisome proliferator-activated receptor  (PPAR) and the deacetylase sirtuin 1 (SIRT1), regulators of fatty acid oxidation and triglyceride lipolysis. IRE1 deficiency exacerbated hepatic steatosis in mice. The abundance of the miR-200 and miR-34 families was also increased in cultured, lipid-overloaded hepatocytes and in the livers of patients with hepatic steatosis. Our findings reveal a mechanism by which IRE1 maintains lipid homeostasis through its regulation of miRNAs, a regulatory pathway distinct from the canonical IRE1-UPR pathway under acute ER stress.
INTRODUCTION
Excessive dietary lipid intake is associated with increased incidence of nonalcoholic fatty liver disease (NAFLD), a spectrum of diseases ranging from steatosis to nonalcoholic steatohepatitis (NASH), and eventually to hepatocellular carcinoma (HCC). Dysfunction of the endoplasmic reticulum (ER) has been proposed to play a crucial role in both the onset of steatosis and progression to NASH (1, 2) . Environmental stressors or pathophysiological alterations can challenge protein-folding homeostasis in the ER, impose stress on the ER, and subsequently lead to accumulation of unfolded or misfolded proteins in the ER lumen. This triggers the unfolded protein response (UPR), leading to activation of three major ER transmembrane stress sensors, including the endoribonuclease [ribonuclease (RNase)] inositolrequiring enzyme 1 (IRE1), protein kinase RNA-like ER kinase (PERK), and activating transcription factor 6 (ATF6) (3, 4) . The UPR represents an important prosurvival response because it not only promotes ER protein homeostasis but also interacts with many different signaling pathways to maintain inflammatory and metabolic equilibrium under stress conditions (5) (6) (7) . When UPR machinery is damaged or the cellular stress exceeds the capacity of UPR, ER stress can trigger proinflammatory response or cell apoptosis that is critically involved in the pathogenesis of a variety of diseases (3, 7, 8) . Among the three UPR pathways, the IRE1/XBP1 (X-box binding protein 1) pathway is the most evolutionarily conserved one. Upon ER stress, IRE1 splices the mRNA encoding XBP1 via its RNase activity, thereby generating functional spliced XBP1 (XBP1s) to activate gene expression of a subset of UPR-associated regulators. In addition to splicing the XBP1 mRNA, IRE1 can process select mRNAs, leading to their degradation, a process known as regulated IRE1-dependent decay (RIDD) (9) (10) (11) . Recent studies suggested that IRE1 undergoes dynamic conformational changes and switches its functions depending on the duration of ER stress (12, 13) . In response to acute ER stress, IRE1 quickly forms oligomeric clusters to initiate Xbp1 mRNA splicing (14) . In addition, the cytosolic domain of IRE1 can act as a scaffold to recruit cytosolic adaptor proteins, for example, tumor necrosis factor (TNF) receptor-associated factor 2 (TRAF2), leading to activation of c-Jun N-terminal kinase (JNK)-mediated signaling pathway associated with inflammatory and metabolic diseases (8, 15) . We and others previously demonstrated that the IRE1/XBP1 UPR pathway protects hepatic lipid accumulation and liver function against hepatic injuries induced by acute ER stress (2, (16) (17) (18) (19) . These studies showed that IRE1 can modulate hepatic de novo lipogenesis or promote very low density lipoprotein (VLDL) assembly and secretion through activation of the XBP1 or RIDD pathway. Most recently, Yang et al. (20) revealed that obesity and associated chronic inflammation repress IRE1 RNase activity by S-nitrosylation of IRE1. Consequently, obesity-induced S-nitrosylation of IRE1 impairs IRE1-mediated Xbp1 mRNA splicing and RIDD activity.
MicroRNAs (miRNAs) are small, noncoding RNAs that regulate gene expression at the posttranscriptional level by base-pairing to their target mRNAs, thereby mediating mRNA decay or translational repression (21, 22) . Maturation of miRNAs involves transcription of about 70-nucleotide RNA intermediates [precursor miRNAs (premiRNAs)] that are transferred to the cytoplasm and further processed to mature miRNA of 20 to 22 nucleotides long (23) . miRNAs control diverse pathways depending on cell types and microenvironment. Of particular note, pre-miRNAs have been reported to be RNA cleavage substrates of the IRE1 RNase activity through the RIDD pathway (10, 24) . Here, we investigated whether the IRE1-miRNA regulatory pathway is involved in hepatic lipid metabolism and hepatic steatosis and found that IRE1 deficiency affects the biogenesis of select miRNAs and, consequently, the abundance of metabolic enzymes that increase hepatic lipid accumulation that contributes to hepatic steatosis.
RESULTS

Hepatocyte-specific Ire1
−/− mice develop severe hepatic steatosis and insulin resistance under high-fat diet To investigate the pathophysiological roles of IRE1 in hepatic lipid metabolism during exposure to excessive nutrients, we fed hepatocytespecific Ire1 −/− and control mice (Ire1 fl/fl ) normal chow (NC) or a high-fat diet (HFD) (45% kcal fat) for 20 weeks. Under NC, deletion of IRE1 in hepatocytes was associated with modest changes in lipid profiles; only serum triglyceride (TG) levels were significantly reduced in the Ire1 −/− mice ( Fig. 1, A and B). However, after HFD, the Ire1 −/− mice displayed significantly higher amounts of hepatic TGs (Fig. 1A ) but lower amounts of serum TGs, cholesterol, low-density protein (LDL), and high-density protein (HDL), compared to the control mice (Fig. 1B) . Histological analysis of the livers, by immunohistochemical staining for adipose differentiation-related protein (ADRP) (Fig. 1C) as well as expression of ADRP measured by Western blot analysis ( fig. S1A ), revealed that HFD-fed Ire1 −/− mice had extensive hepatic microvesicular steatosis characterized by the accumulation of small lipid droplets in the cytosols. In comparison, the HFD-fed control (Ire1 fl/fl ) mice developed less severe macrovesicular steatosis characterized by engorgement of the hepatocyte by large fat globules. These observations suggest that IRE1 deletion results in severe hepatic steatosis with hypolipidemia.
Next, we evaluated whether Ire1 −/− livers developed a NASHlike phenotype. Histological analyses based on hematoxylin and eosin (H&E) staining and Sirius red staining for hepatic collagen deposition (Fig. 1C) identified increased hepatic lobular inflammation, hepatocyte ballooning, and fibrosis in the livers of HFD-fed Ire1 −/− mice, compared to those from HFD-fed control mice. Hepatic inflammation and fibrosis scoring indicated that the HFD-fed Ire1 −/− mice had a NASH-like phenotype (Fig. 1D) . Because NASH is associated with type 2 diabetes, we evaluated the impact of hepatocyte-specific IRE1 deficiency on glucose homeostasis. On an NC diet, Ire1 −/− mice were superficially indistinguishable from the control mice in insulin sensitivity or in defending blood glucose ( fig. S1 , B and C). However, after 19 weeks on an HFD, the Ire1 −/− mice showed decreased insulin sensitivity, as reflected by higher serum glucose levels after intraperitoneal injection of insulin (Fig. 1E) . Furthermore, in response to intraperitoneal injection of glucose, the HFD-fed Ire1 −/− mice displayed discernible reduction in glucose tolerance, compared to the control animals (Fig. 1F) . In addition, the Ire1 −/− mice gained more body weight after 6 weeks on an HFD ( fig. S1D ). In sum, these data suggest that, in the absence of IRE1 in hepatocytes, mice are prone to developing metabolic disorders, characterized by hepatic steatosis and insulin resistance.
IRE1 RNase activity is impaired in the livers of HFD-fed mice and in patients with hepatic steatosis Next, we sought to understand the role(s) of IRE1 within the liver during nutrient excess. IRE1 is a bifunctional enzyme that processes a kinase domain and an RNase domain. First, we measured IRE1 activity in the liver of NC-or HFD-fed mice. After 20 weeks of HFD feeding, the amount of total IRE1 protein in mouse livers was increased ( Fig. 2A) , suggesting that IRE1 expression was up-regulated by HFD. Furthermore, the amount of phosphorylated IRE1 protein, as determined by Western blot analysis through a Phos-tag SDSpolyacrylamide gel electrophoresis (SDS-PAGE) (25) , was also increased in the liver of mice after HFD (Fig. 2B) . Under ER stress, IRE1 is autophosphorylated to cause conformational shifts that increase its RNase activity to splice the Xbp1 mRNA or select mRNAs or miRs through the RIDD pathway (9, 11, 26) . Contrary to the increased protein abundance of IRE1, the amounts of the spliced Xbp1 mRNA (Fig. 2C ) and XBP1 protein (Fig. 2D) were repressed in the liver of mice under HFD, compared to that of mice under NC, suggesting that IRE1 RNase activity was deactivated in the liver under HFD. The obese condition reportedly represses IRE1 RNase activity and Xbp1 mRNA splicing by S-nitrosylation of IRE1, whereas the same condition increases IRE1 phosphorylation (20) . S-nitrosylation, the covalent attachment of a nitrogen monoxide group to the thiol side chain of cysteine residues, represents an important mechanism for dynamic, posttranslational modulation of protein activities (27) . We used a biotin switch method to enrich S-nitrosylated proteins in the livers of NC-or HFD-fed mice and then examined S-nitrosylated IRE1 proteins in the mouse livers by Western blot analysis. Through this approach, we detected significantly enhanced S-nitrosylation of IRE1 in the livers of HFD-fed mice, compared to that of NC-fed mice (Fig. 2E) . Immunoblotting analysis showed that expression of total IRE1 protein in the livers of HFD-fed mice was higher than in those of NC-fed mice (Fig. 2, A and E). It is possible that HFD-induced S-nitrosylation of IRE1 repressed IRE1 enzymatic activity, which stimulated expression of IRE1 protein in the liver as a feedback regulation. Furthermore, we used an in situ immunofluorescence staining approach to visualize S-nitrosylated IRE1 proteins in the livers of NC-or HFDfed mice. Consistent with the biotin switch Western blot analysis, in situ immunofluorescence staining showed that the levels of nitrosylated IRE1 proteins were significantly increased in the liver hepatocytes of HFD-fed mice (Fig. 2F) . The specificity of S-nitrosylated IRE1 staining signals was confirmed by immunofluorescent staining of S-nitrosylated IRE1 in liver tissues from S-nitrosoglutathione reductase (GSNOR)-deficient or inducible nitric oxide synthase (iNOS)-deficient mice fed an HFD ( fig. S2 ). Next, we evaluated whether hepatic steatosis promotes S-nitrosylation of IRE1 in human patients with metabolic complications. In situ detection of S-nitrosylated IRE1 proteins in steatotic and nonsteatotic liver samples from patients indicated that the amount of S-nitrosylated IRE1 protein was significantly increased in the hepatocytes from patients with hepatic steatosis (Fig. 2G) . Together, these data indicated that S-nitrosylation of IRE1 is increased in the fatty livers of both human and mouse and that impaired IRE1 RNase activity in the fatty livers may result from S-nitrosylation modification.
IRE1 deficiency increases the abundance of a subset of miRNA clusters in the steatotic livers of HFD-fed mice and patients Because HFD impairs IRE1 RNase activity in processing Xbp1 mRNAs, we wondered whether the noncanonical IRE1-RIDD pathway is associated with the NASH-like hepatic steatosis developed in the Ire1 −/− mice under HFD. In particular, IRE1 can process select premiRNAs, leading to their degradation through the RIDD pathway ( fig.  S3A ) (10) . We therefore tested for hepatic-specific, IRE1-dependent changes to the miRNAs known to regulate metabolism in mouse livers. Liver-and pathway-specific miRNA quantitative real-time PCR (qPCR) array revealed that expression of a subset of miRNAs, which function as important regulators in lipid metabolism, was increased in the livers of Ire1 −/− mice fed NC or an HFD ( . These data suggested that a subset of miRNAs, which function as facilitators of hepatic steatosis, was increased in the livers of HFD-fed mice and that IRE1 plays a role in repressing these miRNAs. Because an HFD decreased IRE1 RNase-mediated splicing of Xbp1 mRNA, the increased abundance of miRNAs in fat-loaded livers or hepatocytes was likely the result of impaired miRNA degradation mediated by the RNase activity of IRE1.
Because impaired IRE1 RNase activity, caused by IRE1 nitrosylation, and up-regulation of select miRNAs were detected in the steatotic livers of HFD-fed mice, we wondered whether these select miRNAs were also up-regulated in the livers of human patients with hepatic complementary DNAs (cDNAs) were amplified by semiquantitative reverse transcription polymerase chain reaction (RT-PCR) from the total RNAs isolated from the mouse livers, followed by Pst I restriction enzyme digestion. Tunicamycin-treated hepatocytes (5 g/ml) were a positive control. Xbp1(S), spliced Xbp1; Xbp1(U), unspliced Xbp1. (D) Western blot analysis of XBP1s protein abundance in IRE1-KO and CTL mice fed NC or an HFD. GAPDH, glyceraldehyde-3-phosphate dehydrogenase (loading control). (E) Abundance of S-nitrosylated (SNO) IRE1, total IRE1, and -actin in the livers of NC-and HFD-fed mice. SNO-IRE1 protein was enriched by a biotin switch method and detected by Western blot analysis. Mouse liver protein lysates incubated with GSNO (100 M; +) or without (−) are positive and negative controls, respectively. (F and G) Representative images (63×) of staining for SNO (green) and IRE1 (red) in the livers from NC-and HFD-fed mice (F) and from patients with or without hepatic steatosis (G). Nuclei were counterstained with 4′,6-diamidino-2-phenylindole (blue). Arrows indicate colocalization of SNO and IRE1, quantified as inferred SNO-IRE1 in the graphs (right). Ascorbate-omitted staining (−AS) are negative controls. Scale bars, 10 m. Data are means ± SEM of n = 4 mice per group (A to E) or n = 8 mice or patients per group (F and G). *P < 0.05, **P < 0.01 by unpaired two-tailed Student's t test.
the select miRNAs and impaired IRE1 RNase activity in human fatty livers.
IRE1-deficient hepatocytes have increased abundance of the miR-34 and miR-200 families and accumulate more neutral lipids
To confirm the role of IRE1 in preventing lipid accumulation in hepatocytes, we isolated hepatocytes from Ire1 −/− and control (Ire1 fl/fl ) mice and incubated them with OA to induce hepatic steatosis in vitro (28) . Consistent with the in vivo experiments, the abundance of IRE1 protein was up-regulated in the OA-loaded hepatocytes (Fig. 4A) , whereas the amounts of the spliced Xbp1 mRNA and XBP1 protein in hepatocytes were suppressed by the treatment with OA (Fig. 4 , B and C). Supporting the role of IRE1 in repressing the miR-200 and miR-34 families in the liver (Fig. 2) , the expression of the miRNA members (namely, miR-200a/b/c, miR-141, miR-429, miR-34a, miR-223, miR-155, and miR-146) was up-regulated in both control and OAtreated hepatocytes upon deletion of Ire1 (Fig. 4 , D and E). To verify hepatic steatosis-associated alterations of IRE1 and the select miRNAs, we incubated Ire1 −/− and control mouse hepatocytes with palmitate, a saturated fatty acid that can induce in vitro hepatic steatosis with additional hepatic injuries (28) . Consistent with the observations with OA, palmitate challenge led to down-regulation of IRE1 RNase activity, as reflected by decreased splicing of Xbp1 mRNA ( fig. S4, A and B) and up-regulation of the select miRNAs, including the miR-200, miR-34, miR-155, miR-233, and miR-146 families ( fig. S4, C and D) .
We then confirmed that IRE1-mediated suppression of miRNA biogenesis was independent of IRE1's canonical signaling transduction through activating XBP1, because overexpression of IRE1, but not the activated XBP1s or green fluorescent protein (GFP), significantly reduced the abundance of miR-200 and miR-34 family members in the control hepatocytes ( S5 ), confirming the role of IRE1 in suppressing the select miRs in hepatocytes through a regulatory mechanism independent of XBP1.
In addition, we examined the impact of IRE1 deletion on hepatic lipid accumulation using in vitro cultured hepatocytes. Consistent with the hepatic steatosis phenotype of Ire1 −/− mice, increased lipid accumulation was observed in OA-treated Ire1 −/− hepatocytes (Fig. 5C ). Even without the addition of OA, a greater amount of neutral lipids accumulated in Ire1 −/− hepatocytes than in control hepatocytes.
IRE1 suppresses the biosynthesis of miR-34 and miR-200 at the pre-miRNA level
Studies have suggested that IRE1 can process mRNA or pre-miRs by recognizing the G/C cleavage site in RNA stem-loops ( fig. S3A ) (10) . IRE1-cleaved miRNAs cannot be processed by Dicer for the maturation process; as a consequence, these miRNAs are destined for degradation. Bioinformatics analysis indicated that pre-miR-200 and pre-miR-34, the amounts of which were up-regulated in Ire1 −/− liver tissues or hepatocytes, have G/C cleavage sites in their stem-loop structures that are potentially recognized by IRE1 (Fig. 6A) . To determine whether IRE1 regulates miRNA expression at the pre-miR level, we assessed the abundance of the primary miRs (pri-miRNAs) and the stem-loop-containing pre-miRNAs for miR-200 and miR-34 in the livers of Ire1 −/− and control mice when fed an NC diet or an HFD. Whereas the abundances of pri-miR-34 and pri-miR-200 were similar in Ire1 −/− and control livers (Fig. 6B) , the abundances of pre-miR-34 and pre-miR-200 in Ire1 −/− livers were significantly higher than those in the control livers under NC or HFD conditions (Fig. 6C) . These results suggested that IRE1 suppresses miR-34 and miR-200 at the pre-miRNA level. Next, we overexpressed pre-miR-200 and pre-miR-34 in −/− cells than it did in the control cells (Fig. 6D) , thus confirming the role of IRE1 in suppressing miR-34 and miR-200 biogenesis at the pre-miRNA level.
To test whether IRE1 directly processes the select miRNAs, we performed in vitro cleavage analysis by incubating pre-miR-200 or pre-miR-34 oligonucleotides with the purified recombinant human IRE1 protein. In the presence of adenosine 5′-triphosphate (ATP), IRE1 processed both pre-miR-200 and pre-miR-34, leading to their degradation (Fig. 6E) . This result validates the role of IRE1 as an RNase that processes pre-miR-34 and premiR-200 and leads to their decay through the RIDD pathway. fig. S6A ), qPCR and Western blot analyses revealed that both protein and mRNA abundances of peroxisome proliferator-activated receptor  (PPAR) and sirtuin 1 (SIRT1), the master regulators of hepatic fatty acid oxidation and TG lipolysis (29, 30) , were significantly reduced in the livers of Ire1 −/− mice or HFD-fed control mice (Fig. 7, A to D) . To confirm the defect of hepatic PPAR caused by IRE1 deficiency, we examined the expression of the PPAR-target genes related to fatty acid oxidation, including Acox1, Cpt1, Cyp4a10, and Cyp4a14, in the livers of Ire1 −/− and control mice under NC or HFD conditions. Expression of Acox1, Cpt1, Cyp4a10, and Cyp4a14 was reduced in Ire1 −/− and control mouse livers under HFD ( fig. S6B) , suggesting that impaired IRE1 activity may lead to repression of hepatic fatty acid oxidation and hepatic steatosis. Furthermore, we examined the acetylation of PGC1, a PPAR transcriptional coactivator that is deacetylated and activated by the deacetylase SIRT1 (31) , in the livers of Ire1 −/− and control mice under NC or HFD conditions. Immunoprecipitation (IP)-Western blot analysis showed that the abundance of acetylated PGC1 protein in the livers of Ire1 −/− mice or HFD-fed control mice was increased, compared to that of NC-fed control mice (Fig. 7E) . The abundance of acetylated PGC1 in HFD-fed Ire1 −/− mice was increased more robustly, compared to that of NC-fed Ire1 −/− mice or HFD-fed control mice. This was consistent with the reduction of SIRT1 and PPAR and increased hepatic steatosis in Ire1 −/− livers, given that SIRT1-mediated deacetylation and activation of PGC1 function are an important regulatory axis of fatty acid oxidation (31) . Together, these results prompted us to speculate that suppression of PPAR and SIRT1 in the absence of IRE1 may account for exacerbated hepatic steatosis observed in the Ire1 −/− mice. Through miRNA base alignment analyses, we identified highconfidence matches for binding sequences of miR-34 and miR-200 (Fig. 7, F and G (Fig. 8, A and B) . Similarly, incubation with the miR-200 or miR-34 antagomir also increased the abundance of Ppar and Sirt1 transcripts in Ire1 −/− hepatocytes incubated with palmitate ( fig. S8,  A and B) . These results indicate that increased amounts of miR-200 and miR-34, caused by IRE1 deficiency, play major roles in repressing PPAR and SIRT1 expression in hepatocytes. Considering the 3′UTR reporter assays (in Fig. 7 , F and G) and miR antagomir results (in Fig. 8, A and B) , miR-200 appears to be dominant over miR-34 in suppressing PPAR abundance, whereas miR-34 appears to be more dominant in suppressing SIRT1 abundance. The mechanism underlying this distinction is an interesting question to be elucidated with future work.
PPAR and SIRT1, the targets of miR-34 and miR-200, are repressed by IRE1 deficiency in the liver
Because IRE1 suppresses biogenesis of miR-200 and miR-34, we hypothesized that increased abundance of the miR-200 and miR-34 families and subsequent down-regulation of PPAR and SIRT1 may account for hepatic steatosis caused by IRE1 deficiency. To test this hypothesis, we first expressed miR-200 or miR-34 antagomir in Ire1 −/− and control hepatocytes incubated with OA or PA (palmitic acid) and then examined lipid accumulation in the hepatocytes. Upon incubation with an miR-200 or miR-34 antagomir, lipid accumulation was significantly reduced in Ire1 −/− hepatocytes ( Fig. 8C  and fig. S8C ). Furthermore, overexpression of PPAR or SIRT1 in oxidation in OA-or PA-treated Ire1 −/− hepatocytes ( Fig. 8D and fig. S9 ), similar to the effect of the miR-200 and miR-34 antagomirs. Notably, exogenous expression of SIRT1 exhibited greater efficacy than expression of PPAR in relieving hepatic lipid accumulation in Ire1 −/− hepatocytes. This is consistent with the fact that SIRT1 functions as an upstream enhancer of PPAR in facilitating fatty acid oxidation and TG lipolysis (29, 30) .
DISCUSSION
Here, we demonstrated a physiological role for the primary UPR transducer IRE1 in maintaining energy homeostasis associated with chronic metabolic conditions, which is distinct from its canonical role in mediating the UPR (Fig. 8E) . IRE1 plays a crucial role in preventing hepatic steatosis by functioning as an RNase to process a subset of miRNAs that are involved in hepatic lipid metabolism. We found that IRE1 RNase processes select pre-miRNAs and thus prevents their maturation. Notably, our findings demonstrated that both splicing of Xbp1 mRNA and activity of IRE1 are defective in the livers of HFDfed mice and in fat-loaded hepatocytes despite phosphorylation and sustained expression of IRE1. Deficiency in IRE1 RNase activity, caused by HFD-or hepatic steatosis-induced S-nitrosylation of IRE1, led to up-regulation of "metabolic" miRNAs. Subsequently, up-regulation of the miRNAs, particularly of the miR-34 and miR-200 families, down-regulates the key metabolic regulators SIRT1 and PPAR in the liver, thus promoting a NASH-like phenotype. Our findings from this study provide new insights into the physiological roles and molecular mechanisms of the UPR signaling in energy homeostasis and metabolic disorders.
It has been implicated that UPR signaling exhibits different patterns under physiological alterations associated with metabolic disease (3, 5, 6) . Depending on acute or chronic pathophysiological conditions, the UPR transducer IRE1 may act as an RNase or a scaffold through its cytosolic domain to modulate inflammatory and/or metabolic stress signaling pathways (8, 15) . It was previously reported that the IRE1-XBP1 pathway was activated in the livers of NASH patients or animal models (32) (33) (34) . However, our study showed that an HFD deactivated IRE1 RNase activity toward both Xbp1 mRNA splicing and select miRNA processing in the liver. This is consistent with studies in the literature reporting that the protective UPR pathway mediated through IRE1 is impaired in the livers of NASH patients or obese animal models (5, 6, 20, 35, 36) . In particular, S-nitrosylation of IRE1, induced by obesity and associated chronic inflammation, uncouples the kinase and RNase functions of IRE1 protein and thus suppresses IRE1 RNase activity and Xbp1 mRNA splicing in the liver (20) . UPR signaling triggered by acute insults or pharmaceutical inducers, for example, tunicamycin and thapsigargin, differs from that activated under physiological alterations (37-39), as confirmed in this study. The stress condition in the liver in the HFD context was not comparable to that associated with advanced or terminal-stage NASH in which liver injuries, such as fibrosis and even cirrhosis, are prominent. Moreover, metabolic diets with nutrient restriction or supplemented with oxidants, such as the methionine and choline-deficient (MCD) diet and the atherogenic (Paigen) diet (40, 41) , are associated with acute stress in the liver that may activate the canonical IRE1-XBP1 UPR pathway. In contrast, simple HFDinduced chronic, pathophysiological conditions can lead to IRE1 nitrosylation and subsequent suppression of IRE1 RNase activity.
Although several studies characterized metabolic phenotypes of Ire1-null mice under acute stress conditions, the current study delineated the phenotypes of conditional Ire1-KO mice under a chronic, metabolic stress condition. Hepatic-specific Ire1-KO mice developed profound NASH, glucose intolerance, and insulin resistance after 20 weeks of HFD. These in vivo results are in line with our in vitro finding that Ire1 −/− hepatocytes are more susceptible to steatosis and lipotoxicity compared with the control hepatocytes. Our analysis indicated that, under prolonged HFD feeding, the IRE1-XBP1 UPR branch was deactivated in the liver, and a subset of miRNAs that are targeted by the IRE1-RIDD pathway was increased. In particular, the expression of two major regulators in fatty acid oxidation and TG lipolysis, the liver-enriched transcriptional activator PPAR and the deacetylase SIRT1, was down-regulated by miR-200 and miR-34 family members in the fat-loaded or Ire1-KO mouse livers or hepatocytes.
In the attempt to define the effector molecules targeted by the IRE1-RIDD pathway in preventing HFD-induced hepatic steatosis, we found that IRE1 regulates the abundance of PPAR and SIRT1 by degrading the miRNAs that target the mRNAs encoding these two factors. We also identified previously unknown targets of the IRE1-mediated RIDD pathway, specifically the miR-200 and miR-34 families, which suppress the expression of PPAR and SIRT1. These add to a growing list of RNA cleavage substrates of the IRE1 RNase. We chose miR-200 and miR-34 for further analyses because these two miRNA families play important roles in stress-induced cell injury and metabolism (42) (43) (44) . For several reasons, our findings suggest direct regulation of the miR-200 and miR-34 families by IRE1 through the RIDD pathway: (i) overexpression of IRE1, but not XBP1, suppressed maturation of miR-200 and miR-34 family members; Mouse liver protein lysates were immunoprecipitated with the anti-PGC1 antibody, followed by immunoblotting (IB) with the anti-acetyl-lysine (Ace-K) antibody. Data are means ± SEM (n = 4 mice per group); *P < 0.05 versus CTL + NC. (F and G) Luciferase reporter assay of suppressive activities of miR-200 or miR-34 family members on the reporter driven by the human PPAR mRNA 3′UTR (F) or SIRT1 mRNA 3′UTR (G). Attenuation of luciferase activity was interpreted as direct binding of miRNAs to the 3′UTR. Data are means ± SEM (n = 3 biological replicates); *P < 0.05, **P < 0.01 versus scramble cotransfection with PPAR or SIRT1 mRNA 3′UTR reporter vector.
(ii) the abundances of pre-and mature miR-200 and miR-34, but not of pri-miR-200 and pri-miR-34, are increased in IRE1-null hepatocytes, suggesting that IRE1 suppresses miRNA biogenesis at the pre-miRNA level; (iii) expression of pre-miR-200 and pre-miR-34 in
Ire1
−/− hepatocytes yielded significantly higher amounts of mature miR-200 and miR-34, compared to that in wild-type control cells; and (iv) in vitro cleavage assays demonstrated that the recombinant IRE1 protein can process pre-miR-200 and pre-miR-34, leading to their degradation. Thus, we conclude that processing and subsequent repression of miRNAs by IRE1 represent an important regulatory mechanism of metabolic homeostasis by the UPR-a regulatory activity that is distinct from the canonical UPR role in coping with ER stress.
MATERIALS AND METHODS
Materials
Chemicals were purchased from Sigma unless indicated otherwise. Synthetic oligonucleotides were purchased from Integrated DNA Technologies Inc. Antibodies against ADRP, IRE1, PPAR, SIRT1, acetylated lysine, PGC1, and XBP1 were purchased from Thermo Fisher Scientific, Cell Signaling Technology, Millipore Corp., Abcam, Sigma, Santa Cruz Biotechnology, and BioLegend, respectively. GSNO was from Sigma.
Mouse experiments
The Ire1 fl/fl mice were generated as we described previously (2, 45) . The IRE1 fl/fl mice were backcrossed with C57BL/6J mice for more than 10 generations to maintain the C57BL strain background. The hepatocyte-specific IRE1-KO mice were generated by crossing Ire1 fl/fl mice with transgenic mice expressing Cre recombinase under the control of the albumin promoter (Alb-Cre). Alb-Cre transgenic mice were purchased from the Jackson Laboratory. Hepatocyte-specific Ire1-KO (Ire1 in the average age of 47, were hepatitis C virus (HCV)/hepatitis B virus (HBV)-negative, and had no NASH or HCC. The human nonsteatosis liver controls were in the average age of 50, were HCV/HBV-negative, and had no NASH or HCC. The use of human liver tissues was approved by the institutional review board as none human subject research.
Measurement of mouse lipid contents
Levels of plasma TG, total cholesterol, HDL, LDL, and VLDL in the mice were determined enzymatically using commercial kits (Roche Diagnostics Corporation). To quantify hepatic TG levels, about 50 mg of mouse liver tissue was homogenized in 5% phosphate-buffered saline, followed by centrifugation. The supernatant was collected for TG measurement using a commercial kit (BioAssay Systems).
Histological scoring for NASH activities
Mouse paraffin-embedded liver tissue sections (5 m) were subjected to H&E staining, ADRP immunohistochemical staining, or Sirius red staining. The histological analysis of H&E-and Sirius red-stained tissue sections were performed for liver inflammation and fibrosis. Hepatic steatosis, hepatocyte ballooning, lobular and portal inflammation, Mallory bodies, and fibrosis were examined and scored according to the modified Brunt scoring system for NAFLD (46, 47) . The grade scores were calculated on the basis of the scores of steatosis, hepatocyte ballooning, lobular and portal inflammation, and Mallory bodies. Hepatic fibrosis was evaluated by Sirius red staining. Each section was examined by a specialist who was blinded to the sample information. Hepatic fibrosis was scored according to the modified Scheuer scoring system for fibrosis and cirrhosis (stages 0 to 4): 0, none; 1, zone 3 perisinusoidal fibrosis; 2, zone 3 perisinusoidal fibrosis plus portal fibrosis; 3, perisinusoidal fibrosis, portal fibrosis, plus bridging fibrosis; and 4, cirrhosis.
qPCR analysis
Total RNA from mouse liver tissues or cultured hepatocytes was isolated by the miRNeasy Mini Kit (Qiagen). For mRNA expression, cDNA was generated from 200 ng of RNA using the High-Capacity cDNA Reverse Transcription Kit (Life Technologies). qPCR was performed using the SYBR Green PCR Master Mix (Applied Biosystems). For miRNA detections, cDNA was generated from 10 ng of small RNAs using a miRCURY LNA cDNA Synthesis kit (Exiqon). qPCR was performed using miR primers synthesized by Exiqon. For pre-miRNA qPCRs, cDNA was generated using the miScript II RT Kit (Qiagen). qPCR was performed using a miScript Precursor Assay kit (Qiagen). For pri-miR qPCRs, cDNA was generated from 500 ng of RNA using the High-Capacity cDNA RT Kit (Life Technologies). qPCR was performed using a TaqMan Pri-miRNA Assay kit (Life Technologies). Amplification and detection of specific products were performed with an Applied Biosystems 7500 Real-Time PCR Systems, using U6 as an internal control for miRNA detection.
Western blot analysis
Total cellular protein lysates were prepared from cultured cells or mouse liver tissue using NP-40 lysis buffer supplemented with protease inhibitors (EDTA-free Complete Mini, Roche). Denatured proteins were separated by SDS-PAGE gels and transferred to polyvinylidene difluoride membranes (GE Healthcare). For the detection of phosphorylated IRE1, 30 g of cellular lysates was loaded in 5% Phos-tag SDS-PAGE gel (Wako Chemicals) and ran according to the manufacturer's instructions. The membranes were incubated with a rabbit or mouse primary antibody and a horseradish peroxidase (HRP)-conjugated secondary antibody. Membrane-bound antibodies were detected by a chemiluminescence detection reagent (GE Healthcare). The signal intensities were determined by Quantity One 4.4.0 (Bio-Rad Life Science).
Generation of IRE1
−/− hepatocyte cell lines and adenoviral infection Primary murine hepatocytes were isolated from mice harboring floxed homozygous Ire1 alleles and immortalized by SV40 T antigen. Immortalized hepatocytes were treated with Ad-Cre to delete the floxed Ire1 exons as we described previously (2) . Recombinant Ad expressing flag-tagged human IRE1 (Ad-IRE1) was provided by Y. Liu (Institute for Nutritional Sciences, Shanghai, China). Adenovirus expressing XBP1s was provided by U. Ozcan (Harvard University). Hepatocytes were infected with Ad-IRE1, Ad-XBP1s, or Ad-GFP at MOI of 100 for 48 hours before the sample collection.
Transfection of pre-miRNA-expressing plasmids Plasmids expressing pre-miR-200 or pre-miR-34 were constructed by inserting human pre-miR-200 sequence (CCAGCUCGGGCAGCC-GUGGCCAUCUUACUGGGCAGCAUUGGAUGGAGUCAGGU-CUCUAAUACUGCCUGGUAAUGAUGACGGCGGAGCCCUGCACG) or human pre-miR-34 sequence (GGCCAGCUGUGAGUGUUUCUUUG-GCAGUGUCUUAGCUGGUUGUUGUGAGCAAUAGUAAGGAAG-CAAUCAGCAAGUAUACUGCCCUAGAAGUGCUGCACGUUGUG-GGGCCC) into pCMV-miR vector between Sgf I and Mlu I site. The empty plasmid served as the control. Cells were transfected with either 100 ng of pre-miR-expressing plasmid or empty plasmid. Samples were collected simultaneously 24 hours after transfection for RNA analysis.
In vitro IRE1-mediated pre-miR cleavage assays
In vitro cleavage of pre-miR-200 and pre-miR-34 by recombinant, bioactive IRE1 protein was carried out as described previously with modifications (17) . Briefly, pre-miR-200 and pre-miR-34 were amplified by PCR using plasmids carrying either human pre-miR-200 or pre-miR-34 sequence as template and primers provided by the manufacturer. Transcription of large-scale RNAs of pre-miR-200 or pre-miR-34 was performed using the T7 RiboMAX Express RNA Production System (Promega). About 1 g of in vitro transcribed miRNAs was incubated with 1 g of bioactive recombinant human IRE1 protein (aa468-end, purchased from SignalChem Inc.) in a buffer containing 25 mM Mops (pH 7.2), 12.5 mM -glycerol-phosphate, 25 mM MgCl 2 , 5 mM EGTA, and 2 mM EDTA. The cleavage reactions were initiated by adding ATP (2 mM). Reaction without ATP was included as the control for each sample. After incubation at 37°C for 30 min, the reaction products were resolved on a 1.2% agarose gel and visualized by ethidium bromide staining.
3′UTR luciferase activity assays
Synthetic oligonucleotides of human PPAR or SIRT1 mRNA 3′UTR were cloned into a luciferase reporter vector system (SwitchGear). Human embryonic kidney (HEK) 293T cells were cotransfected with 100 ng of PPAR or SIRT1 3′UTR reporter and 0.1 nmol of miR mimics (Exiqon) or 100 ng of pre-miR plasmids using DharmaFECT Duo transfection reagent (Dharmacon) according to the manufacturer's protocol. After 48 hours, luciferase activity was measured. A reduced firefly luciferase expression indicates the direct binding of miRs to the cloned target sequence.
Biotin switch assay
Biotin switch-Western blot analysis was performed as previously described (20, 48) . Biotinylated proteins were pulled down using the NanoLink Streptavidin Magnetic Beads (Solulink), and the IRE1 protein was examined using a rabbit anti-IRE1 antibody (Cell Signaling Technology). In situ detection of S-nitrosylated proteins was performed as previously described (49, 50) . Free thiols in liver tissue sections were first blocked using Hepes/EDTA/neocuproine buffer (2% SDS) containing 20 mM methyl methanethiosulfonate. Biotinylated proteins were labeled using streptavidin conjugated with Alexa Fluor 488. The liver tissue sections were then subjected to immunostaining for IRE1 using the IRE1 antibody and an anti-rabbit immunoglobulin G secondary antibody conjugated to Alexa Fluor 568. The images were observed by using Zeiss 700 confocal microscopy. Colocalizations of S-nitrosylated IRE1 were quantified using ImarisColoc software (Bitplane) and analyzed for Pearson's correlation coefficient.
Electrophoretic analysis of Xbp1 splicing
Total RNAs isolated from mouse liver tissues or cultured hepatocytes were subjected to semiquantitative RT-PCR using the following primers to amplify a 451-base pair (bp) unspliced Xbp1 fragment or a 425-bp spliced Xbp1 fragment: 5′-CCTTGTGGTTGAGAACCAGG-3′ and 5′-CTAGAGGCTTGGTGTATAC-3′. To distinguish the spliced from unspliced Xbp1 transcripts, PCR products were subjected to Pst I restriction enzyme digestion, which only cleaves the intron included in the unspliced Xbp1 cDNA to give a 154-bp and a 297-bp fragment, leaving the spliced Xbp1 cDNA intact (26) . -Actin transcript was also amplified by semiquantitative RT-PCR as internal control. The Pst I-digested products were analyzed by 2% agarose gel, and the Xbp1 signals were quantified by National Institutes of Health (NIH) ImageJ software.
Statistical analysis
Experimental results are shown as means ± SEM (for variation between animals or experiments). The mean values for biochemical data from the experimental groups were compared by a paired or unpaired, two-tailed Student's t test. When more than two treatment groups were compared, one-way analysis of variance (ANOVA) followed by least significant difference post hoc testing was used. Statistical tests with P < 0.05 were considered significant.
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